High blood pressure is stroke, myocardial infarction, heart failure and chronic kidney disease an important risk factor, 50% -60% of stroke, myocardial infarction, 40% -50% of the occurrence of elevated blood pressure. As the highest incidence of cardiovascular disease, hypertension and deaths each year worldwide more than seven million cases, and has become the dominant human death risk factors. According to epidemiological data estimated that China’s annual two million people a new stroke, new myocardial infarction issued 500,000 people who died from cardiovascular and cerebrovascular diseases were 3 million people. The major cardiovascular and cerebrovascular diseases each year in direct medical costs 1,300 billion, of which the medical expenses for high blood pressure reached 36.6 billion yuan. Based on the prevalence of hypertension, the community prevention and treatment of high blood pressure the city will be included in the “Eleventh Five-year” science and technology development planning major projects sub-item.

Chinese Hypertension League has told us by the Chinese Medical Doctor Association of cardiovascular physicians and the Chinese Hypertension League branch of the two authorities co-sponsored the “China Survey of blood pressure control (CHINA STATUS)” the results officially announced. It showed that: in 2009, in the top three hospitals for treatment of hypertension compliance rate was only 31.1%, nearly 7 into not reached because often forget to wear clothes antihypertensive drugs or omitted. Relevant experts in hypertensive patients through the newspaper this: a lot of medicine in the era is now over, the simplified treatment requires only one day to take a drug.

The latest survey to fill gaps in seven-year epidemiological survey

Survey of blood pressure control in China is China’s first trans-regional, inter-hospital, cross-sections of the large-scale hypertension treatment status. The survey covered 22 cities nationwide, 100 three hospitals, in the Cardiovascular Section, Department of Nephrology, Endocrinology, all subjects included a total of 5186 cases of hypertension.

“The last published census data of hypertension in China in 2002, when the compliance rate of patients with hypertension was 6.1%, have been treated for hypertension in patients with compliance rate of 25%,” the Chinese Hypertension League President Professor Liu Lisheng, told reporters: “The survey reflect the top three hospitals for treatment of hypertension in patients with compliance rates, the survey has filled seven years of my high blood pressure related to flow of the transfer of data gaps. “credits China, director of vascular medicine knowing a member of the Chinese Medical Association Section of Cardiology, Dr. Hu a Great professor said: “The survey in-depth analysis of the factors affecting the rate of blood pressure and compliance, for we seek to improve the compliance rate of blood pressure and effective strategies to minimize the risk of death and social burden of high blood pressure provides a useful hint.”

Leak medication compliance rates can reduce the 7 into a

“High blood pressure patients need lifelong treatment for patients with poor compliance, its effectiveness will be undermined.” Professor Hu Yida the treatment of hypertension in talking about compliance issues, told reporters that the survey found that: the current leak medication (one week ≥ 3 times the number of missing clothes) in hypertensive patients than in patients who never leak blood pressure medication compliance rate has dropped 72%. The more drugs, the greater the possibility of missing clothes, and a variety of drug side effects and economic factors that force the patient can not afford on their own reductions.

Survey results also showed: More than 50% of patients taking 2-5 kinds of antihypertensive drugs, more than 40% of patients had the phenomenon of missing clothing. Professor Hu Yida, said: “If a drug can have a multi-drug efficacy, safety and good at the same time, it will greatly improve patient compliance to treatment.”

This reporter learned from some of the hospitals in Chengdu City, learned of hypertensive patients, in order to step-down as quickly as possible, they often have to simultaneously take 3-5 kinds of drugs. Cardiovascular experts have also told reporters that, for some of the more severe patients, a single drug has been difficult to blood pressure under control, “this part of the patient, but to take joint treatment and compound preparation of means treatment.”

One day one can simplify the medication

“We need to take more effective treatment methods to achieve powerful buck.” Said Professor Hu Yida. So, is there a lot of medication may be reduced to eating from a drug, and can play a very good step-down effect? Hu told reporters that a major treatment of high blood pressure, strengthen, simplify and optimize the “three” will become new trends. “Patient compliance and drug efficacy is the impact of the survey revealed the rate of blood pressure and compliance are two key factors, which for us in clinical practice how to take effective treatment strategies provide a useful hint.” Said Professor Hu Yida “At the moment, the world’s new trends in the treatment of hypertension is also applied with a strengthened, simplified and optimization characteristics of monolithic compound preparation to meet the patient on drug efficacy, tolerability and safety of a variety of needs.” he told reporters, with the strengthen the characteristics of single compound preparation of blood pressure control rate can be greatly improved, research confirms that valsartan / amlodipine single compound preparation for single-drug treatment failure in patients treated for 16 weeks will enable 90% of patients with compliance; 2,000 patients were registered to participate in clinical research in China confirmed that such a single compound preparation for people with mild to moderate hypertension in Chinese patients can be realized more than 70% compliance rate. “The drug is only eat one a day, thereby reducing the leakage dose or forget to take the medication issue.”